Pear Therapeutics- Warrants (01/12/2026) Total Current Liabilities

The latest total current liabilities for PEARW is $49M as of December 2022. That compares with $47M in the prior-year period — up 4.8% year over year. Investors often review this figure alongside Pear Therapeutics- Warrants (01/12/2026)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, PEARW's total current liabilities moved from $47M to $49M — a 4.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Pear Therapeutics- Warrants (01/12/2026)'s operating scale or balance-sheet position.

A total current liabilities figure of $49M for PEARW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting PEARW's total current liabilities ($49M), review year-over-year change from $47M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.